CAXTON CORP 13D and 13G filings for Addex Therapeutics Ltd:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:30 pm Sale | 2022-12-31 | 13G | Addex Therapeutics Ltd ADXN | CAXTON CORP | 35,942 0.900% | -79,782 (-68.94%) | Filing |
| 2022-02-14 4:07 pm Sale | 2021-12-31 | 13G | Addex Therapeutics Ltd ADXN | CAXTON CORP | 115,724 6.000% | -90 (-0.08%) | Filing |
| 2021-02-16 4:19 pm Purchase | 2020-12-31 | 13G | Addex Therapeutics Ltd ADXN | CAXTON CORP | 115,815 8.400% | 115,815 (New Position) | Filing |